Research News

2011 SGO News: GI Risk Clarified for Bevacizumab

Ovarian cancer patients had a twofold greater risk of gastrointestinal adverse effects when bevacizumab was added to chemotherapy, but the angiogenesis inhibitor did not exacerbate other known risks for GI events, data from a large prospective trial…

Read on

2011 SGO News: Genetic Test May Spot Increased Risk for Inherited Ovarian Cancer

Ovarian cancer patients had a twofold greater risk of gastrointestinal adverse effects when bevacizumab was added to chemotherapy, but the angiogenesis inhibitor did not exacerbate other known risks for GI events, data from a large prospective trial…

Read on

2011 SGO News: Menopause Symptoms Common after Gynecologic Cancer

Most survivors of gynecologic cancers have menopausal symptoms, and at least one in four takes replacement hormones, results of the first study of its kind showed…

Read on

2011 SGO News: Mutation Link to Ovarian Cancer Disputed

Developers of a genetic-susceptibility test for ovarian cancer might have jumped the gun, according to an OCRF-funded research consortium that found no association between a KRAS mutation and risk of the cancer…

Read on

2011 SGO News: ESAs Linked to Mortality Risk in Ovarian Cancer

Cancer recurrence and death occurred significantly more often in ovarian cancer patients treated with erythropoietin-stimulating agents (ESAs), data from a retrospective cohort review showed…

Read on

2011 SGO News: PARP Inhibitor Active in Ovarian Cancer

Almost half of patients with heavily pretreated ovarian cancer benefited from an investigational PARP inhibitor, results of a phase I study showed…

Read on

2011 SGO News: MicroRNA May Help Predict Ovarian Cancer Response

Changes in expression of a microRNA showed potential for predicting response to the angiogenesis inhibitor bevacizumab (Avastin) in recurrent serous ovarian cancer, according to results of a small study reported here…

Read on

2011 SGO News: Medicare Patients Get Less Than Best Ovarian Cancer Care

Most older patients with ovarian cancer may receive care that doesn't measure up to national standards, according to an analysis of a National Cancer Institute (NCI) database and Medicare claims data…

Read on

Study Shows that Few Lives Saved with Current Ovarian Cancer Screening Technology

12/21/2010 Available ovarian cancer screening only slightly reduces the number of deaths from the disease, a new study finds…

Read on

OCRF Research Finds microRNA Regulates Cancer Stem Cells

11/08/2010 OCRF Grantee Lin Zhang, MD  Research has provided strong support for the ovarian cancer stem cell hypothesis, which proposes that a rare subpopulation of tumor cells—cancer stem cells– have the unique ability to initiate and…

Read on

Understanding Ovarian Cancer: Part One of OCRF’s Educational Series

  09/28/2010 View a seven-part series about ovarian cancer, brought to you by the Ovarian Cancer Research Fund.The series is narrated by Douglas A. Levine, MD, of Memorial Sloan-Kettering Cancer Center.  Dr…

Read on

OCRF Statement on OVA1

Some of you may have recently seen articles in the newspaper or on TV about a test called OVA1…

Read on